Učitavanje...
Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery
There is no specific test for diagnosing neuromyelitis optica spectrum disorder (NMOSD), a disabling autoimmune disease of the central nervous system. Instead, diagnosis relies on ruling out other related disorders with overlapping clinical symptoms. An urgency for NMOSD biomarker discovery is under...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2020-09-01
|
| Serija: | Metabolites |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2218-1989/10/9/374 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Učitavanje...